Pyrosequencing Shifts Emphasis Toward Near-Term Profitability; Company Reduces Operating Expenses by Approximately $7 Million on Annual Basis
October 10, 2002 08:54 ET | Pyrosequencing
UPPSALA, Sweden, Oct. 10, 2002 (PRIMEZONE) -- Pyrosequencing AB (Stockholm:PYROA) (Other OTC:PYRSF) today announced that in conjunction with a program aimed to accelerate the route to profitability,...
Nokia to publish third quarter financial results on Thursday, October 17, 2002
October 10, 2002 08:40 ET | Nokia Oyj
Nokia will publish its third quarter 2002 financial results on Thursday, October 17 at approximately 12 noon Helsinki time (CET+1). The press release will be available on the Nokia website immediately...
Nokia julkistaa kolmannen neljänneksen tulostietonsa 17.10.2002
October 10, 2002 08:40 ET | Nokia Oyj
Nokia julkistaa vuoden 2002 kolmannen neljänneksen tulostietonsa torstaina, 17. lokakuuta noin klo 12. Tiedote on nähtävissä Nokian Internet-sivuilla välittömästi julkistamisen jälkeen....
Industri-Matematik Intl. Corp
Industri-Matematik Announces Corporate Restructuring
October 10, 2002 08:13 ET | Industri-Matematik Intl. Corp
MT. LAUREL, New Jersey, Oct. 10, 2002 (PRIMEZONE) -- Industri-Matematik International Corp. (Nasdaq:IMIC) -- the Order Company -- today announced a corporate restructuring designed to substantially...
Nokia strengthens its local R&D partnership in China
October 10, 2002 08:00 ET | Nokia Oyj
  Nokia today announces the establishment a new branch office in Hangzhou and the inauguration of the Nokia Hangzhou R&D center. Mr. Lv Zushan, Standing Vice Governor of Zhejiang Province,...
Peab to Extend the E6 and the West Coast Main Line
October 10, 2002 07:39 ET | PEAB
FOERSLOEV, Sweden, Oct. 10, 2002 (PRIMEZONE) -- Peab (Stockholm:PEABb) have won the contract to build a stretch of motorway on the E6 north of Uddevalla. Along with other things, the work involves...
New Results from Active Biotech's SAIK-MS Project
October 10, 2002 07:34 ET | Active Biotech
LUND, Sweden, Oct. 10, 2002 (PRIMEZONE) -- At the Medicon Valley BioConference in Malmo, Active Biotech (Other OTC:ACTBF) today published new data about the development of its SAIK-MS substance for...
New results from Active Biotech’s SAIK-MS project
October 10, 2002 07:01 ET | Active Biotech
Data was presented showing that oral treatment with SAIK-MS (Laquinimod) in tablet form inhibits the progress of disease in various MS-like animal models. Laquinimod is the generic name given by the...
October 10, 2002 07:00 ET | Klövern AB (publ)
Nya resultat rörande Active Biotechs projekt SAIK-MS
October 10, 2002 06:55 ET | Active Biotech
Vid konferensen presenterades data som visar att oral behandling i tablettform med SAIK-MS (Laquinimod) hämmar utvecklingen av olika MS-liknande sjukdomsmodeller hos djur. Laquinimod är det generiska...